cjc 1295 ipamorelin clinical trial growth hormone secretagogue safety CJC-1295 & Therapy in Austin CJC 1295
Description
NR, not reported
Participants were reevaluated every 3 to 5 years using detailed on-site physical examinations and questionnaires
P.MuschE
BV-2 cells were cultured on poly-L-ornithine-coated coverslips (13 mm
